167298-18-2

Basic information

• Product Name: 2-Chloro-N-(2,2-diphenylethyl)-adenosine 2',3',5'-tribenzoate
• Synonyms: 2-Chloro-N-(2,2-diphenylethyl)-adenosine 2',3',5'-tribenzoate
• CAS NO: 167298-18-2
• Molecular Weight: 794.263
• Mol File: 167298-18-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-Chloro-N-(2,2-diphenylethyl)-adenosine 2',3',5'-tribenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-N-(2,2-diphenylethyl)-adenosine 2',3',5'-tribenzoate(167298-18-2)
• EPA Substance Registry System: 2-Chloro-N-(2,2-diphenylethyl)-adenosine 2',3',5'-tribenzoate(167298-18-2)

Safety Data

• Hazardous Substances Data: 167298-18-2(Hazardous Substances Data)

Upstream product

• 3963-62-0 2,2-Diphenylethylamine 
• 14215-97-5 1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose 
• 5451-40-1 2,6 dichloropurine 
• 15373-23-6 (2R,3R,4R,5R)-2-((benzoyloxy)methyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl dibenzoate 

Downstream Products

• 98383-42-7 (2R,3R,4S,5R)-2-[2-chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-5-hydroxymethyl-tetrahydro-furan-3,4-diol 
• 167297-07-6 (3aS,4S,6R,6aR)-6-[6-(2,2-Diphenyl-ethylamino)-2-(2-piperidin-1-yl-ethylamino)-purin-9-yl]-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carboxylic acid ethylamide 
• 167296-96-0 1-Deoxy-1-[6-[(2,2-diphenylethyl)amino]-2-[[2-(1H-imidazol-4-yl)ethyl]amino]-9H-purin-9-yl]-N-ethyl-2,3-O-(1-methylethylidene)-β-D-ribofuranuronamide 
• 167298-15-9 (3aS,4S,6R,6aR)-6-[2-Chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carboxylic acid ethylamide 
• 167298-17-1 (3AS,4S,6R,6AR)-6-[2-chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carboxylic acid 
• 167298-55-7 (3aS,4S,6R,6aR)-6-[2-Chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carbonyl chloride 

Relevant articles and documents

The discovery and synthesis of highly potent, A(2a) receptor agonists

A series of N6,2-disubstituted adenosine analogues have been synthesized and their functional activity measured against A(2a) and A1 receptors. Examples of compounds with both a lipophilic N6-substituent and amino-functionalized 2-position were highly active at the A(2a) receptor on the human neutrophil. (C) 2000 Published by Elsevier Science Ltd. All rights reserved.